By Ben Hirschler LONDON (Reuters) - BTG, the healthcare group best known for treating rattlesnake bites and varicose veins, is expanding into lung care by buying a Californian firm that has developed a device to prop open airways. The British company said on Thursday it would pay an initial $230 million and up to $245 million in performance-related future milestone payments to acquire privately-owned PneumRx. The U.S. firm's flagship product is the RePneu Coil for advanced emphysema, which tethers small airways open to prevent their collapse. ... via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment